2022
DOI: 10.1016/j.bcp.2022.115041
|View full text |Cite
|
Sign up to set email alerts
|

Carbon monoxide signaling and soluble guanylyl cyclase: Facts, myths, and intriguing possibilities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 156 publications
0
8
0
Order By: Relevance
“…One view is that relatively high local concentrations of CO can still be maintained when there is little NO left to diffuse to sGC because CO is much more stable than NO. As a result, the concentration of CO is sufficient to competitively inhibit the binding of NO, while the initiated sGC activity by CO is much lower, allowing for an impactful blocking effect [ 154 ]. In addition to competing for the downstream binding sites, CO has regulatory effects on NOS and NO on HO.…”
Section: Comentioning
confidence: 99%
“…One view is that relatively high local concentrations of CO can still be maintained when there is little NO left to diffuse to sGC because CO is much more stable than NO. As a result, the concentration of CO is sufficient to competitively inhibit the binding of NO, while the initiated sGC activity by CO is much lower, allowing for an impactful blocking effect [ 154 ]. In addition to competing for the downstream binding sites, CO has regulatory effects on NOS and NO on HO.…”
Section: Comentioning
confidence: 99%
“…CO is a well-known gaseous ligand for various hemoproteins. In vivo , at least 25 hemoproteins were observed to bind CO with K D s spanning almost 8 orders of magnitude from low nM to high μM range ( Lu et al, 2022 ). The ability for CO to activate sGC was first discovered in 1987 in a study of the anti-platelet aggregation activity of CO ( Brune and Ullrich, 1987 ).…”
Section: Introductionmentioning
confidence: 99%
“…The problem of CO-dependent regulation of sGC is further exacerbated by the high affinity for CO of the abundant cellular heme-containing globins. CO binding affinity of hemoglobin, myoglobin, neuroglobin or cytoglobin is 3–6 orders of magnitude higher than that of sGC ( Lu et al, 2022 ). Therefore in vivo , it is highly unlikely that any significant amount of sGC-CO is formed.…”
Section: Introductionmentioning
confidence: 99%
“…11 It controls various critical cellular processes, with mitochondria being its primary target, and manifests anti-inflammatory, antiproliferative, and cytoprotective properties. [12][13] It soon gained attention as a promising therapeutic agent in several settings, such as organ transplantation or cancer treatments, [14][15][16][17][18] but its acute toxicity 19 poses severe limitations in the administration under a clinical scenario. A controlled and targeted release is, therefore, essential.…”
Section: Introductionmentioning
confidence: 99%